0001725160-22-000005.txt : 20220105 0001725160-22-000005.hdr.sgml : 20220105 20220105174928 ACCESSION NUMBER: 0001725160-22-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blackwell Kimberly CENTRAL INDEX KEY: 0001816465 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 22512649 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 4 1 wf-form4_164142295564507.xml FORM 4 X0306 4 2022-01-03 0 0001725160 Zentalis Pharmaceuticals, Inc. ZNTL 0001816465 Blackwell Kimberly C/O ZENTALIS PHARMACEUTICALS, INC. 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 1 0 0 0 Common Stock 2022-01-03 4 M 0 1000 47.80 A 6000 D Common Stock 2022-01-03 4 S 0 1000 83.74 D 5000 D Stock Option (Right to Buy) 47.8 2022-01-03 4 M 0 1000 0 D 2030-06-30 Common Stock 1000.0 38000 D The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021. The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant on July 1, 2020. By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kimberly Blackwell 2022-01-05